Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pneumonia I: Introduction01:30

Pneumonia I: Introduction

205
Pneumonia is an acute respiratory infection that targets the lungs, specifically the alveoli. These tiny air sacs, essential for oxygen exchange, become engorged with pus and fluid, severely hindering breathing, decreasing oxygen absorption, and causing significant pain and discomfort during respiration.
Risk Factors
Various factors influence the likelihood of developing pneumonia. Age plays a crucial role, with infants, children under two, and individuals over 65 at increased risk due to their...
205
Pneumonia III: Complications and Assessment01:30

Pneumonia III: Complications and Assessment

153
Pneumonia poses the potential for numerous complications that warrant consideration. These complications include the following:
153
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

11.3K
The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
11.3K
Pneumonia II: Pathophysiology01:29

Pneumonia II: Pathophysiology

212
The pathophysiology of pneumonia involves the following steps:
212
Pneumonia IV: Management01:28

Pneumonia IV: Management

297
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
297
Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.01:25

Chronic Obstructive Pulmonary Disease-III: Symptoms and Complications.

2.7K
Understanding the variety of primary symptoms and systemic complications that characterize chronic obstructive pulmonary disease (COPD) is crucial for healthcare professionals.
Symptoms of COPD can be classified as primary or systemic. Primary symptoms relate to reduced airflow, while systemic or extrapulmonary symptoms relate to COPD's broader impact on the body.
Primary Symptoms of COPD:
2.7K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Eosinopenia and prognosis in severe community-acquired pneumonia.

Pneumonia (Nathan Qld.)·2026
Same author

Hypercapnia at admission, regardless of acidosis, may worsen the outcome of hospitalised patients with chronic obstructive pulmonary disease exacerbations.

Internal and emergency medicine·2026
Same author

Diagnostic BioFire® FilmArray® Pneumonia Panel Plus versus standard microbial culture in bronchiectasis exacerbations.

Pneumonia (Nathan Qld.)·2026
Same author

Immunosuppressed patients with COVID-19 pneumonia in ICU: clinical characteristics and factors influencing outcomes.

Pneumonia (Nathan Qld.)·2025
Same author

Systemic Immune Dysregulation in Patients With Bronchiectasis and Chronic Pseudomonas aeruginosa Infection.

Archivos de bronconeumologia·2025
Same author

Comparative analysis of illumina and oxford nanopore sequencing platforms for 16S rRNA profiling of respiratory microbial communities.

Scientific reports·2025
Same journal

Advances in Sarcoidosis.

Archivos de bronconeumologia·2026
Same journal

Spanish Clinical Practice Guidelines for the Diagnosis and Management of Alpha-1 Antitrypsin Deficiency: 2026 Update.

Archivos de bronconeumologia·2026
Same journal

Thoracic Sympathectomy for Harlequin Syndrome.

Archivos de bronconeumologia·2026
Same journal

Prognostic Significance of Electrocardiographic Findings in Hemodynamically Stable Patients With Acute Pulmonary Embolism: Insights From the RIETE Registry.

Archivos de bronconeumologia·2026
Same journal

Endothelial and Angiogenic Biomarkers in Obstructive Sleep Apnea: Longitudinal Associations With Continuous Positive Airway Pressure.

Archivos de bronconeumologia·2026
Same journal

Robotic Resection of Ectopic Paratracheal Thymoma: A Case Report.

Archivos de bronconeumologia·2026
See all related articles

Related Experiment Video

Updated: Jun 2, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K

Risk Factors and Outcomes Associated With Polymicrobial Infection in Community-Acquired Pneumonia.

Catia Cillóniz1, Davide Calabretta2, Andrea Palomeque3

  • 1Institut d'Investigacions Biomèdiques August Pi i Sunyer (IDIBAPS), Spain; Faculty of Health Sciences, University Continental, Huancayo, Peru.

Archivos De Bronconeumologia
|January 14, 2025
PubMed
Summary
This summary is machine-generated.

Polymicrobial pneumonia in hospitalized adults is linked to worse outcomes and higher 30-day mortality. Identifying risk factors like multilobar pneumonia is crucial for managing this severe form of community-acquired pneumonia (CAP).

Keywords:
Community-acquired pneumoniaMicrobial aetiologyPneumoniaPolymicrobial

More Related Videos

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

467
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.3K

Related Experiment Videos

Last Updated: Jun 2, 2025

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria
11:32

Following in Real Time the Impact of Pneumococcal Virulence Factors in an Acute Mouse Pneumonia Model Using Bioluminescent Bacteria

Published on: February 23, 2014

15.0K
Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes
03:53

Growing a Cystic Fibrosis-Relevant Polymicrobial Biofilm to Probe Community Phenotypes

Published on: April 19, 2024

467
A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness
12:21

A Mouse Model for the Transition of Streptococcus pneumoniae from Colonizer to Pathogen upon Viral Co-Infection Recapitulates Age-Exacerbated Illness

Published on: September 28, 2022

2.3K

Area of Science:

  • Infectious Diseases
  • Pulmonology
  • Clinical Microbiology

Background:

  • Polymicrobial pneumonia is associated with increased disease severity in hospitalized patients.
  • Understanding the prevalence and risk factors for polymicrobial community-acquired pneumonia (CAP) is vital for effective patient management.
  • This study investigates clinical characteristics, outcomes, and mortality predictors in adult CAP patients.

Purpose of the Study:

  • To determine the prevalence of polymicrobial pneumonia in hospitalized adult CAP patients.
  • To identify clinical characteristics and risk factors associated with polymicrobial pneumonia.
  • To evaluate the impact of polymicrobial infection on in-hospital and 30-day mortality.

Main Methods:

  • Retrospective analysis of prospectively collected data from 5114 adult CAP patients.
  • Established etiology in 1703 patients, with polymicrobial infection identified in 14% of this subgroup.
  • Multivariable analysis was used to identify independent risk factors for polymicrobial etiology and 30-day mortality.

Main Results:

  • Polymicrobial infections were found in 14% of CAP patients with a defined etiology, more common in ward than ICU patients.
  • Frequent polymicrobial combinations included Streptococcus pneumoniae with respiratory viruses, Haemophilus influenzae, or Staphylococcus aureus.
  • Polymicrobial etiology was associated with higher rates of inappropriate initial antimicrobial treatment, in-hospital, 30-day, and 1-year mortality.
  • Multilobar pneumonia was a risk factor, while fever was associated with a lower risk for polymicrobial etiology.
  • Polymicrobial infection independently predicted a higher risk of 30-day mortality.

Conclusions:

  • Polymicrobial infection in hospitalized CAP patients is linked to poorer outcomes, particularly in elderly individuals with comorbidities.
  • Polymicrobial infection is an independent risk factor for 30-day mortality in adult CAP.
  • Clinical factors such as multilobar pneumonia should be considered when assessing the risk of polymicrobial CAP.